Clinical trial · Interventional
Feasibility of Exercise With Post-Op Lung Cancer Patients
Determining the Feasibility of Post-Operative Training for Patients Diagnosed With Non-Small Cell Lung Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Primary Objective: To examine the effects of an exercise training program on cardiopulmonary fitness in early-stage postoperative non-small cell lung cancer patients undergoing adjuvant chemotherapy Secondary Objectives: Determine patients' adherence levels to such a program during adjuvant chemotherapy Explore the effects of exercise training on treatment compliance and toxicity, and quality of life. To explore the effects of exercise training on markers of inflammation (e.g., c-reactive protein, immune response) in patients undergoing adjuvant chemotherapy for early-stage non-small cell lung cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non-Small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Exercise | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- ECG stress test
- timeFrame
- 8 weeks, 16 weeks
Secondary outcomes (4)
- measure
- Safety
- timeFrame
- 8 weeks, 16 weeks
- measure
- adherence levels
- timeFrame
- 8 and 16 weeks
- description
- The study will determine patients' adherence levels to such a program during adjuvant chemotherapy.
- measure
- Treatment compliance and toxicity, and quality of life
- timeFrame
- 8 and 16 weeks
- description
- The study will explore the effects of exercise training on treatment compliance and toxicity, and quality of life.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Legal age (\>18 years old) * Absence of contraindications to chemotherapy * Ability to read and understand English * Signed informed consent prior to the initiation of study procedures * Primary attending oncologist approval. Exclusion Criteria: * Acute myocardial infarction (3-5 days) * Unstable angina * Uncontrolled arrhythmias causing symptoms or hemodynamic compromise * Syncope * Acute endocarditis * Acute myocarditis or pericarditis * Uncontrolled heart failure * Acute pulmonary embolus or pulmonary infarction * Thrombosis of lower extremities * Suspected dissecting aneurysm * Uncontrolled asthma * Pulmonary edema * Room air desaturation at rest ≤85% * Respiratory failure * Acute noncardiopulmonary disorder that may affect exercise performance or be aggravated by exercise * Mental impairment leading to inability to cooperate. * Finally, patients presenting with no medical history will not be eligible for study participation.
References
Publications (0)
Data not yet available